Vitamin-C Co.'s Bid To Duck Antitrust Suit Came Too Late

Law360, New York (February 21, 2013, 7:38 PM EST) -- A New York federal judge on Wednesday denied China Pharmaceutical Group Ltd.'s bid to escape exposure for the alleged price-fixing by a vitamin C-producing subsidiary days before the antitrust case was scheduled to go to trial, saying CPG waited too long to raise issues related to its liability.

U.S. District Judge Brian M. Cogan denied a motion from CPG to distance itself from its Weisheng Pharmaceutical Co. Ltd. unit, based on the company's claims that vitamin C purchasers were required, and failed, to establish its liability...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.